David A Cory - Net Worth and Insider Trading
David A Cory Net Worth
The estimated net worth of David A Cory is at least $25,160 dollars as of 2024-11-13. David A Cory is the President and CEO of Eiger BioPharmaceuticals Inc and owns about 2,960 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $25,160. Details can be seen in David A Cory's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Cory has not made any transactions after 2019-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David A Cory
David A Cory Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David A Cory owns 1 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of David A Cory’s form 4 insider trades.
Insider Ownership Summary of David A Cory
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-11 | director & President and CEO |
David A Cory Latest Holdings Summary
David A Cory currently owns a total of 1 stock. David A Cory owns 2,960 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of February 4, 2019, with a value of $25,160.
Latest Holdings of David A Cory
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2019-02-04 | 2,960 | 8.50 | 25,160 |
Holding Weightings of David A Cory
David A Cory Form 4 Trading Tracker
According to the SEC Form 4 filings, David A Cory has made a total of 0 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 8 shares on February 4, 2019, which cost David A Cory around $3,208.
Insider Trading History of David A Cory
- 1
David A Cory Trading Performance
GuruFocus tracks the stock performance after each of David A Cory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David A Cory is -22.22%. GuruFocus also compares David A Cory's trading performance to market benchmark return within the same time period. The performance of stocks bought by David A Cory within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David A Cory's insider trading performs compared to the benchmark.
Performance of David A Cory
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.81 | | | | | |
| Relative Return to S&P 500(%) | -4.74 | | | | | |
David A Cory Ownership Network
Ownership Network List of David A Cory
Ownership Network Relation of David A Cory
David A Cory Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
David A Cory is the director & President and CEO of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, David A Cory made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
David A Cory Mailing Address
Above is the net worth, insider trading, and ownership report for David A Cory. You might contact David A Cory via mailing address: 350 Cambridge Avenue, Suite 350, Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
